News

Deal Announcements

Chiasma Adds $4 Million Venture Capital Debt

Thursday, March 10, 2011 5:36:00 AM PDT | VentureDeal Staff
Newton Center, Massachusetts  --  Biotechnology company Chiasma has secured an additional $4 million in venture capital debt, according to an SEC regulatory filing.

Chiasma has developed technology that enables drugs to be administered into the bloodstream without need for an injection.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1